Target intelligence / Profile preview

Transport protein

Molecular classification
Transporter, Ion channel, Carrier protein, Pump, Pore
01

Overview

Transport proteins are a vast group of membrane-bound proteins that facilitate the movement of ions, small molecules, and macromolecules across biological membranes, which are otherwise impermeable to many polar or large substances (Wikipedia; Study.com). This broad classification includes several major superfamilies, most notably the solute carriers (SLC), ATP-binding cassette (ABC) transporters, and various ion channels and pumps (PMC; Tocris Bioscience). These proteins are essential for fundamental cellular processes such as nutrient uptake, waste excretion, signal transduction, and the maintenance of electrochemical gradients (Longdom Publishing; bioRxiv). Because they regulate the entry and exit of substances, they are primary determinants of drug pharmacokinetics, influencing how medications are absorbed, distributed, and eventually cleared from the body (Vertex; eLife). Dysfunctions in transport proteins are linked to a wide range of pathologies, including genetic disorders like cystic fibrosis, metabolic diseases like diabetes, and the development of multidrug resistance in cancer (PMC; Vrije Universiteit Brussel). Consequently, specific members of this class are high-value therapeutic targets for a diverse array of drugs, including SGLT2 inhibitors for diabetes, SSRIs for depression, and diuretics for hypertension (PMC; Tocris Bioscience; PMC).

Other names
Membrane transport proteinCarrier proteinTransporterPermeasePoreTransmembrane transport protein
02

Mechanism of action

Drugs targeting these proteins typically act by inhibiting the translocation of substrates through competitive or non-competitive binding, occluding pores, or modulating ATPase activity in primary active transporters (PMC; Tocris Bioscience).

03

Biological functions

Molecular transportCellular homeostasisNutrient uptakeIon balanceWaste removalSignal transductionDrug absorption and elimination
04

Disease associations

CancerCystic fibrosisDiabetesNeurological disordersCardiovascular diseaseEpilepsyDrug resistance
05

Safety considerations

Off-target drug-drug interactionsUnintended electrolyte imbalancesToxicity due to impaired waste excretionSubstrate specificity overlap
06

Interacting drugs

Dapagliflozin

6 more in the full profile.

07

Biomarkers

SLC transporter expression levelsABC transporter mutation statusP-glycoprotein activitySubstrate clearance rates

Beyond the preview

Go deeper on Transport protein.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transport protein.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call